Jagat Pharma, a prestigious name in the Ayurvedic healthcare sector, continues building social impact with its inclusive goals, spreading the light of vision far and wide. This time, Jagat Pharma has opted to conduct a free eye care camp at Indraprastha Institute of Information Technology, Delhi (IIIT-Delhi) to cater to all the students and faculty members on the Institute’s 15th foundation day.
This unique eye care camp aimed to provide comprehensive eye care solutions to the students, alumni, and faculty members of IIIT-Delhi. Beyond routine eye check-ups, attendees were privileged to consult with seasoned eye specialists who provided personalized recommendations tailored to their unique needs. The one-on-one interaction gave participants invaluable insights and guidance for maintaining optimal eye health.
Dr. Mandeep Singh Basu, Director of Jagat Pharma, expressed his enthusiasm about this transformative initiative. He stated, “At Jagat Pharma, our mission has always been to enhance the quality of life through Ayurvedic Eye solutions. Collaborating with IIIT-Delhi for this eye care camp aligns perfectly with our commitment to promoting holistic health for all without any surgery. We firmly believe that good vision is the foundation of a productive and fulfilling life, and we are honored to have been a part of this enlightening endeavor. The free eye check-up camp had a profound impact, benefiting several attendees and making them aware of how to take regular eye care. It provided them an invaluable opportunity to detect and address potential eye conditions that might have gone unnoticed.”
An IIIT-Delhi spokesperson shared their thoughts on this collaboration, saying “IIIT-Delhi is dedicated to the well-being of its students, alumni, and faculty members. This collaborative eye care camp with Jagat Pharma has provided our community with preventive eye care services and reinforced our commitment to holistic education. . We would like to express our sincere appreciation to Jagat Pharma for organizing a complimentary eye check-up camp in commemoration of our 15th anniversary.”
Dr. Basu Eye Hospital, a renowned name in the realm of Ayurvedic eye care, on the occasion of Prime Minister Narendra Modi’s birthday took a step towards holistic and accessible healthcare by organizing a free eye check-up camp at the revered Bangla Sahib Gurudwara in association with the Delhi Sikh Gurudwara Management Committee. The camp took place on 17th September and aimed to provide effective Ayurvedic eye treatment to those in need and emphasized Dr. Basu Eye Hospital’s unwavering commitment to the community’s well-being.
For over four decades, Dr. Basu Eye Hospital has been at the forefront of providing Ayurvedic solutions for various eye ailments, and has successfully treated lakhs of individuals. This initiative was a testament to their dedication to extending accessible eye care to the local populace.
The camp offered consultations, eye tests, and distribution of eye medications to experience for all the individuals visiting the Holy Bangla Sahib Gurudwara and raising a sense of awareness lacking about eye care.
The event was led by UP Ratna honoured Dr. Mahendra Singh Basu the founder of Dr Basu Eye Hospital and Dr. Mandeep Singh Basu Senior eye specialist and Director Dr Basu Eye Hospital , who conducted thorough eye examinations and diagnosis by applying extensive knowledge and experience.
The event featured a team of 10 highly skilled Ayurvedic eye Doctors along with 15 other medical staff members of Dr Basu Eye Hospital. The eye camp successfully served over 500+ local beneficiaries in a remarkable display of community engagement.
“I extend my heartfelt gratitude for the invaluable opportunity to serve our community and champion Ayurvedic practices in eye care. This eye camp stands as a shining testament to our unwavering commitment to ensure better eye health for everyone, transcending barriers of access and means.
Our mission has always been rooted in the belief that every individual, regardless of their background, deserves the gift of clear vision and a brighter future. It’s our privilege to play a distinctive role in this journey toward better eye health for all,” commented Dr. Mahendra Singh Basu, Founder of Dr.Basu Eye Hospital.
While elaborating the vision of Dr. Mahendra, Dr. Mandeep Singh Basu, Director, Dr. Basu Eye Hospital, said, “At Dr. Basu Eye Hospital, we believe in the power of Ayurveda to heal and transform lives. This camp is an extension of our mission to provide holistic and sustainable eye care solutions to all, irrespective of their socio-economic backgrounds.“
Iqbal Singh Lalpura, remarked: “Dr. Basu Eye Hospital’s initiative of providing free eye check-ups at Gurudwara Bangla Sahib is commendable in extending healthcare services to the society. Vision is a precious gift of God, and this camp aligns with our holistic well-being commitment.”
Bhupinder Singh Bhullar, Member of the Delhi Sikh Gurudwara Management Committee, shared his views on the camp, “We are proud to collaborate with Dr. Basu Eye Hospital in this noble endeavor. Vision is a precious gift, and through this camp, we hope to touch the lives of many. It’s a manifestation of our commitment to the welfare of the community.”
In an ongoing endeavor to promote disease awareness, Allergan, an AbbVie company, has recently drawn attention to the critical importance of early diagnosis and specialized treatment for Chronic Migraine by arranging a conclave. Allergan has placed strong emphasis on educating patients about the symptoms, consequences and treatments associated with Chronic Migraine. Despite the profound impact of Chronic Migraine on individuals’ lives, it remains largely underestimated and underdiagnosed.
Chronic migraine (CM) is classified as a primary headache disorder when patients have fifteen or more headache days per month for over 3 months, and at least eight of these exhibit migraineurs features. It impacts about 1.4–2.2% of the global population, leading to notable morbidity.
Migraines are typically associated with adults, but it’s crucial to acknowledge that children can also experience this condition. Chronic migraine typically develops from episodic migraine due to an increase in attack frequency and/or the involvement of several other risk factors associated with migraine chronification. The incidence of chronic migraine peaks during midlife, impacting an individual’s most productive years. Chronic Migraine usually affects women (1.7–4.0%) compared to men (0.6–0.7%), showing a biased prevalence toward women. This condition emphasizes the need for a comprehensive approach to understanding and treating it. This involves multiple disciplines and considers both biological and psychosocial factors.
Delving into the Chronic Migraine issue Dr Rajashekhar Reddi, Consulting Neurologist highlighted that “Chronic migraines are a complex neurological disorder with multiple contributing factors. While they can be challenging to manage, a combination of lifestyle modifications, medications, and therapeutic interventions can help reduce the frequency and severity of attacks.” He further added, “Chronic pain is a major health concern especially amongst women. It is a serious concern that needs a proper intervention approach to improve their overall quality of life.”
Recognizing chronic migraine as a condition often underestimated and inadequately treated, Allergan, an AbbVie company, is committed to advancing scientific knowledge and aims to empower healthcare providers to offer enhanced care to migraine sufferers. This will aid them provide access to care, appropriate medications, and rejuvenate lives through education and connections within the migraine community.
The significant effects of chronic migraine are well known, and many studies have investigated its consequences. These involve problems like disability from headaches, lower quality of life related to health, more medical and mental health issues at the same time and using more healthcare resources.
HCG Cancer Hospital Bengaluru, one of India’s leading cancer care chains, is proud to announce a groundbreaking pilot study to transform the treatment landscape for head and neck cancer patients with Low Dose Immunotherapy. Known for its relentless commitment to innovation and value-based care since its inception in 1989, HCG is taking a significant step towards advancing cancer care in India and globally. The successful pilot study on Low Dose Immunotherapy Nivolumab with NACT has demonstrated remarkable efficacy and is highly cost-effective, providing an economical therapy option without additional side effects.
The multicentric, open-labeled, prospective, randomized study assesses the effectiveness of neoadjuvant therapy combining low-dose immunotherapy Nivolumab and the TPF regimen (docetaxel, cisplatin, and 5-fluorouracil) compared to NACT with the TPF regimen alone. It has a potential role in improving the quality of life and longevity of patients with locally advanced carcinoma of the buccal mucosa.
As part of the pilot study, a total of 12 cases were studied between the age group of 54 to 76 years. All twelve patients experienced significant tumor reduction of over 90%, providing an economical and side-effect-free therapy through low-dose immunotherapy. In the pilot study, standard neoadjuvant chemotherapy is combined with low-dose Nivolumab immunotherapy, administering 40 mg every two weeks, as opposed to the full dose of 3 mg per kg of body weight.
Speaking at the occasion, Dr. B S Ajaikumar, Executive Chairman of Healthcare Global Enterprises Limited, said, “HCG has been tirelessly striving to serve the larger cause of cancer care through breakthrough innovation and value-based care. Cancer is fast becoming a chronic disease, and a sea change has occurred in how we stage cancer as we adopt a multi-disciplinary approach to treatment. At HCG, head and neck cancer cases represent a significant portion of the caseload. Despite the comprehensive approach, preventing the recurrence and spread of these cancers remains a significant challenge. Today, with this announcement, we embark on a journey to revolutionize head and neck cancer treatment. This study has the potential to be a game-changer in the sphere of head and neck cancer treatment. The initiative reflects HCG’s commitment to advancing research and academia in India, positioning the organization as a leader in this vital healthcare domain.”
Dr. Satheesh C T, Consultant – Medical and Hemato Oncology, Director of Clinical Trials HCG Cancer Hospital Bangalore, said, ” Head and neck cancers pose a substantial global health issue, comprising 4.5% of total worldwide cancer cases with a mortality rate of 4.6%. The burden is exceptionally high in Asia, notably in India, where they make up nearly 35% of all cancer cases among individuals aged 40-60. We are enthusiastic about the potential benefits of combining low-dose immunotherapy with neoadjuvant chemotherapy in head and neck cancers. This study presents a cost-effective solution without compromising the quality of care. This approach not only delivers promising clinical results but also in a manner that is highly economical for patients.”
Enthused by these promising findings, HCG will initiate a study to explore the potential benefits of low-dose immunotherapy alongside neoadjuvant chemotherapy in head and neck cancers. Through this study spanning across multiple HCG centers in India, HCG will strive to unfold a highly effective and affordable cancer treatment option in the management of head and neck cancers.
On the occasion of World Literacy Day, Gurugram based NGO Heart joins hands with District Public Library, Gurugram, Bhiwani and Karnal for the noble cause of promoting literacy and education within our community. World Literacy Day book donation event was held in the District Library at Gurugram, Bhiwani and Karnal on 8th September 2023. Close to 500 books will be distributed among the specified areas.
The 21 year old founder, Shirin Batra of the charitable trust (NGO) – “Heart” initiated a book donation drive to promote the right to literacy and education within our community. This event took place on the World Literacy Day where all the avid readers and underprivileged kids will be addressed. They distributed a combination of Educational books (competitive exam books, ncerts, dictionary, atlas, discovery books and more), Novels (kids + adults) and Kids storybooks.
“We are enthusiastic about contributing to the District Public Library Gurugram and supporting the cause of literacy on World Literacy Day. To be organised at the District Public Library, it witnessed participation from avid readers and underprivileged kids. Education forms the cornerstone of our society’s advancement, and we firmly believe in providing access to high-quality reading materials that can inspire, educate, and entertain individuals from all walks of life. We hope that these books will ignite the curiosity and enthusiasm for learning among the library’s visitors”, shares Vivek Kalia, Joint Secretary Information Public Relations and Languages , Government of Haryana.
Shirin Batra, founder, Heart NGO shares, “Heart – The name that instantly struck to my mind – the idea that it has the word ‘Art’ in it and the sole reason for me to start this initiative – to make people’s heart happy & that I am doing it with all my heart, made me come up with this name. Engaging in social work made me realise the importance of kindness and compassion. It caused an impact on the way I pursue objectives and make sensitive decisions. Heart conducts various donation drives, campaigns and art exhibition fundraisers. This initiative made me realise that everything is beyond materialistic things and what matters is the happiness we can find in little things”.
Revinto’s foray into skincare signifies its dedication to growth and its vision to redefine the industry. customers can rest assured that REVINTO skincare products are backed by a deep understanding of holistic well-being.
Understanding the gentle nature of Ayurveda and its nurturing effects on the skin, Revinto made the natural decision to expand into skincare. By harnessing the power of Ayurvedic principles and combining them with pharmaceutical expertise, Revinto skincare products offer a harmonious blend of science and nature. Crafted with care, these products not only deliver visible results but also promote overall skin health. With this diversification, Revinto brings the nourishing qualities of Ayurveda to a wider audience, providing a revitalising skincare experience.
Dr Jithendra Shetty. Managing director- Revinto Said “As the Managing Director of Revinto and an Ayurvedic doctor, my unwavering vision is to unveil the hidden treasures of Ayurveda, breathing new life into forgotten Indian techniques. Our mission is to present this ancient wisdom to the modern world, empowering individuals with a range of authentic and chemical-free beauty and wellness solutions
Adding on Dr Shetty Said, “With a relentless commitment to innovation and customer satisfaction, we are dedicated to positioning Revinto as the ultimate destination for natural and high-performance skincare. Join us on this transformative journey, where tradition meets innovation and ancient beauty secrets are reimagined for the modern individual.”
Leading Revinto’s charge towards excellence is Dr Jithendra Shetty, the Managing Director and an accomplished Ayurvedic doctor. With his extensive expertise in both pharmaceuticals and traditional Ayurveda, brings a unique perspective to the skincare industry. This combination of scientific understanding and ancient wisdom gives Revinto’s skincare products an unparalleled edge, making them a trusted choice among consumers.